相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alterations of Stress-Related Glucocorticoids and Endocannabinoids in Hair of Chronic Cocaine Users
Clarissa D. Voegel et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
COX-2 pathway is upregulated in ultra-high risk individuals for psychosis
Cicero A. C. Pereira et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2022)
Biomarkers of the Endocannabinoid System in Substance Use Disorders
Francisco Navarrete et al.
BIOMOLECULES (2022)
Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
Tertia D. Purves-Tyson et al.
MOLECULAR PSYCHIATRY (2021)
Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention
Ana Catalan et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2021)
Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention
Robin M. Murray et al.
PSYCHOLOGICAL MEDICINE (2021)
Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study
Benjamin Perry et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Chemokines, cytokines and substance use disorders
Olivia C. Ahearn et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia
Michael Maes et al.
MOLECULAR NEUROBIOLOGY (2021)
Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis
Annika Seppala et al.
SCHIZOPHRENIA RESEARCH (2021)
Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review
Ray Alsuhaibani et al.
BMC PSYCHIATRY (2021)
The concomitant use of cannabis and cocaine coexists with increased LPS levels and systemic inflammation in male drug users
Camila Bastos Ribeiro et al.
CYTOKINE (2021)
First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection
Michael Maes et al.
CELLS (2021)
Inflammatory Biomarkers in Addictive Disorders
Alvaro Morcuende et al.
BIOMOLECULES (2021)
Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls
Tory R. Spindle et al.
ADDICTION BIOLOGY (2021)
Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
Wataru Omori et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Cytokines: From Clinical Significance to Quantification
Chao Liu et al.
ADVANCED SCIENCE (2021)
The Role of Cytokines in the Pathogenesis of Schizophrenia
Bartosz Dawidowski et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
Sora Park et al.
SCHIZOPHRENIA RESEARCH (2020)
Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid
Viktoria Johansson et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist
Sunil U. Nayak et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Stress-related suppression of peripheral cytokines predicts future relapse in alcohol-dependent individuals with and without subclinical depression
Helen C. Fox et al.
ADDICTION BIOLOGY (2020)
Brain structural changes in cannabis dependence: association with MAGL
Peter Manza et al.
MOLECULAR PSYCHIATRY (2020)
Interactions Between Alcohol and the Endocannabinoid System
George Kunos
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review
Bruno Pedraz-Petrozzi et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Altered peripheral blood compounds in drug-naive first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
Nuray Cakici et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
Bruce D. Hammock et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases
Nuria Garcia-Marchena et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis
Claire Adams et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
Leonardo Brunetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Nuria Garcia-Marchena et al.
SCIENTIFIC REPORTS (2020)
Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
Ole Kohler-Forsberg et al.
FRONTIERS IN PSYCHIATRY (2020)
Emerging roles of lysophospholipids in health and disease
Shu Ting Tan et al.
PROGRESS IN LIPID RESEARCH (2020)
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders
Anastasia Levchenko et al.
HELIYON (2020)
Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
Jane A. Mitchell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Eicosanoids in the gastrointestinal tract
John L. Wallace
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Neuroimmune mechanisms of psychostimulant and opioid use disorders
Rebecca S. Hofford et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children
Francisco Madrid-Gambin et al.
BIOLOGICAL PSYCHIATRY (2019)
Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia
Leo Gotoh et al.
PSYCHIATRY RESEARCH (2019)
The Role of Eicosanoids in Alzheimer's Disease
Roger G. Biringer
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Measuring Disturbance of the Endocannabinoid System in Psychosis A Systematic Review and Meta-analysis
Amedeo Minichino et al.
JAMA PSYCHIATRY (2019)
Cytokine alterations in first-onset postpartum psychosis-clues for underlying immune dysregulation
Gopinath Sathyanarayanan et al.
ASIAN JOURNAL OF PSYCHIATRY (2019)
THE NEUROSCIENCE OF DRUG REWARD AND ADDICTION
Nora D. Volkow et al.
PHYSIOLOGICAL REVIEWS (2019)
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
N. Cakici et al.
PSYCHOLOGICAL MEDICINE (2019)
Alcohol and cannabis use alter pulmonary innate immunity
Kristina L. Bailey et al.
ALCOHOL (2019)
In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype
Michael Maes et al.
NEUROTOXICITY RESEARCH (2019)
Inflammatory biomarkers in psychosis and clinical high risk populations
Shannon Delaney et al.
SCHIZOPHRENIA RESEARCH (2019)
Cytokine Alterations in Schizophrenia: An Updated Review
Sara Momtazmanesh et al.
FRONTIERS IN PSYCHIATRY (2019)
The relationship between nicotine and psychosis
Harriet Quigley et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
Alexandre K. Wang et al.
SCHIZOPHRENIA BULLETIN (2018)
Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis
Marie Stefanie Kejser Starzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study
Dorota Frydecka et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms
Tyler A. Lesh et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila et al.
SCIENCE (2018)
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence
Nuria Garcia-Marchena et al.
ADDICTION BIOLOGY (2017)
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Michael J. Lacagnina et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?
Feifei Qiu et al.
ONCOTARGET (2017)
Chemokines from a Structural Perspective
Michelle C. Miller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD
Carlo Agostoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities
Marita Pruessner et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry
Kiran V. Sandhu et al.
TRANSLATIONAL RESEARCH (2017)
Evaluation of Oxidant/Antioxidant Status and Cytokine Levels in Patients with Cannabis Use Disorder
Huseyin Bayazit et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2017)
Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical integration of Clinical and experimental evidence
Souhel Najjar et al.
FRONTIERS IN PSYCHIATRY (2017)
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
Anniella Isgren et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
The Role of NFkB in Drug Addiction: Beyond Inflammation
S. E. Nennig et al.
ALCOHOL AND ALCOHOLISM (2017)
BDNF/NF-κB Signaling in the Neurobiology of Depression
Ariel Caviedes et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis
Robin Nusslock et al.
BIOLOGICAL PSYCHIATRY (2016)
Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10
Fernanda Pedrotti Moreira et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Altering the course of schizophrenia: progress and perspectives
Mark J. Millan et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Plasma interleukin-6 and executive function in crack cocaine-dependent women
Mateus Luz Levandowski et al.
NEUROSCIENCE LETTERS (2016)
Can symptoms help in differential diagnosis between substance-induced vs independent psychosis in adults with a lifetime diagnosis of cocaine use disorder?
Esperanza Vergara-Moragues et al.
PSYCHIATRY RESEARCH (2016)
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia
Kayla A. Chase et al.
PSYCHIATRY RESEARCH (2016)
Early interventions in risk groups for schizophrenia: what are we waiting for?
Iris E. Sommer et al.
NPJ SCHIZOPHRENIA (2016)
Bipolar Disorder and Inflammation
Joshua D. Rosenblat et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
Synthetic and Natural Inhibitors of Phospholipases A2: Their Importance for Understanding and Treatment of Neurological Disorders
Wei-Yi Ong et al.
ACS CHEMICAL NEUROSCIENCE (2015)
The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response via TLR4 in Mouse Macrophages
Binggang Cai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The Endocannabinoid System and its Modulation by Phytocannabinoids
Vincenzo Di Marzo et al.
NEUROTHERAPEUTICS (2015)
Genetics and genomics of psychiatric disease
Daniel H. Geschwind et al.
SCIENCE (2015)
Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings
Maria Pedraz et al.
FRONTIERS IN PSYCHIATRY (2015)
[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users
Jenny Ceccarini et al.
ADDICTION BIOLOGY (2015)
Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity
Pedro Araos et al.
ADDICTION BIOLOGY (2015)
Eicosanoid storm in infection and inflammation
Edward A. Dennis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
Larry Keen et al.
JOURNAL OF BEHAVIORAL MEDICINE (2015)
Classical endocannabinoid-like compounds and their regulation by nutrients
Karen Kleberg et al.
BIOFACTORS (2014)
NF-κB control of T cell development
Steve Gerondalds et al.
NATURE IMMUNOLOGY (2014)
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis
Francesco Mori et al.
NEUROMOLECULAR MEDICINE (2014)
Neuroimmune regulation of homeostatic synaptic plasticity
Horia Pribiag et al.
NEUROPHARMACOLOGY (2014)
Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients
Carlos Roncero et al.
PSYCHIATRY RESEARCH (2014)
Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia
Borja Garcia-Bueno et al.
SCHIZOPHRENIA BULLETIN (2014)
Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity
Francisco Javier Pavon et al.
ADDICTION BIOLOGY (2013)
Lysophospholipids and their receptors in the central nervous system
Ji Woong Choi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid
Laura Orio et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Cytokines in bipolar disorder: A systematic review and meta-analysis
Klaus Munkholm et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans
Carmen Walter et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
TNF-α Downregulates Inhibitory Neurotransmission through Protein Phosphatase 1-Dependent Trafficking of GABAA Receptors
Horia Pribiag et al.
JOURNAL OF NEUROSCIENCE (2013)
Mechanisms of Involvement of Eicosanoids and their Precursors in the Pathophysiology and Treatment of Schizophrenia
Luise Schmidt et al.
MEDICINAL CHEMISTRY (2013)
Psychostimulant Abuse and Neuroinflammation: Emerging Evidence of Their Interconnection
Kenneth H. Clark et al.
NEUROTOXICITY RESEARCH (2013)
Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers
Emilio Fernandez-Egea et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Secondary psychoses: an update
Matcheri S. Keshavan et al.
WORLD PSYCHIATRY (2013)
Drugs of abuse and increased risk of psychosis development
Anand Gururajan et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2012)
Cigarette Smoking and Inflammation: Cellular and Molecular Mechanisms
J. Lee et al.
JOURNAL OF DENTAL RESEARCH (2012)
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers
J. Hirvonen et al.
MOLECULAR PSYCHIATRY (2012)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Cannabis Use and Earlier Onset of Psychosis
Matthew Large et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Involvement of p38/NF-κB signaling pathway in the nucleus accumbens in the rewarding effects of morphine in rats
Xueqin Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Induction of innate immune genes in brain create the neurobiology of addiction
F. T. Crews et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice
Laura Musazzi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Implication of CCR2 Chemokine Receptor in Cocaine-Induced Sensitization
Jean Marc Trocello et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system
William Rostene et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report
Jennifer M. Loftis et al.
NEUROTOXICITY RESEARCH (2011)
The Prevention of Schizophrenia
Alan S. Brown et al.
SCHIZOPHRENIA BULLETIN (2011)
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Rosa C. Paolicelli et al.
SCIENCE (2011)
Phospholipase A2 activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12
Stefan Smesny et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Induction of Innate Immune Gene Expression Cascades in Brain Slice Cultures by Ethanol: Key Role of NF-κB and Proinflammatory Cytokines
Jian Zou et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Alan S. Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Amphetamine toxicities Classical and emerging mechanisms
Bryan K. Yamamoto et al.
ADDICTION REVIEWS 2 (2010)
Circulating Cytokines as Biomarkers of Alcohol Abuse and Alcoholism
Rajeshwara N. Achur et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
SDF-1α/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus
Silke Heinisch et al.
NEUROPHARMACOLOGY (2010)
Lipopolysaccharide: Biosynthetic pathway and structure modification
Xiaoyuan Wang et al.
PROGRESS IN LIPID RESEARCH (2010)
Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8
Lauren M. Ellman et al.
SCHIZOPHRENIA RESEARCH (2010)
Cognitive Functioning Prior to the Onset of Psychosis: The Role of Fetal Exposure to Serologically Determined Influenza Infection
Lauren M. Ellman et al.
BIOLOGICAL PSYCHIATRY (2009)
Nuclear Factor κB Signaling Regulates Neuronal Morphology and Cocaine Reward
Scott J. Russo et al.
JOURNAL OF NEUROSCIENCE (2009)
Endocannabinoid signaling in microglial cells
Nephi Stella
NEUROPHARMACOLOGY (2009)
MODULATION OF COCAINE-INDUCED ACTIVITY BY INTRACEREBRAL ADMINISTRATION OF CXCL12
J. Treckl et al.
NEUROSCIENCE (2009)
LONG TERM EXPOSURE TO THE CHEMOKINE CCL2 ACTIVATES THE NIGROSTRIATAL DOPAMINE SYSTEM: A NOVEL MECHANISM FOR THE CONTROL OF DOPAMINE RELEASE
A. Guyon et al.
NEUROSCIENCE (2009)
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
Akira Monji et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2009)
Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia
Holger J. Sorensen et al.
SCHIZOPHRENIA BULLETIN (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Psychiatric comorbidity in young cocaine users: induced versus independent disorders
M. Jesus Herrero et al.
ADDICTION (2008)
Cyclooxygenase-2 in synaptic signaling
Hongwei Yang et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse
Bryan K. Yamamoto et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment
Liya Qin et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Large recurrent microdeletions associated with schizophrenia
Hreinn Stefansson et al.
NATURE (2008)
Psychiatric genetics:: progress amid controversy
Margit Burmeister et al.
NATURE REVIEWS GENETICS (2008)
Lipid signalling in disease
Matthias P. Wymann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Stress as a neuroinflammatory condition in brain:: Damaging and protective mechanisms
Borja Garcia-Bueno et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology
Hed Harizi et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants
James J. Mahoney et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Opinion -: Chemokines:: a new class of neuromodulator?
William Rostene et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in Schizophrenia
Stefan Smesny et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients:: Impact of cannabis use
F. Markus Leweke et al.
SCHIZOPHRENIA RESEARCH (2007)
Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans
Roberta Pacifici et al.
ADDICTION (2007)
Toxoplasma gondii as a risk factor for early-onset schizophrenia:: Analysis of filter paper blood samples obtained at birth
Preben Bo Mortensen et al.
BIOLOGICAL PSYCHIATRY (2007)
Multiple actions of the chemokine stromal cell-derived factor-1 alpha on neuronal activity
Alice Guyon et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2007)
Unravelling the genome: a review of molecular genetic research in schizophrenia
J. Sanders et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2007)
BHT blocks NF-κB activation and ethanol-induced brain damage
Fulton Crews et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Synaptic scaling mediated by glial TNF-α
D Stellwagen et al.
NATURE (2006)
Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways
KCM Verhoeckx et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Cytokines and alcohol
FT Crews et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
Prenatal infection as a risk factor for schizophrenia
AS Brown
SCHIZOPHRENIA BULLETIN (2006)
Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness
MO Cunningham et al.
JOURNAL OF NEUROSCIENCE (2006)
Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia
NA Bowden et al.
SCHIZOPHRENIA RESEARCH (2006)
The role of phospholipases A2 in schizophrenia
M. H. Law et al.
MOLECULAR PSYCHIATRY (2006)
Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications
J Read et al.
ACTA PSYCHIATRICA SCANDINAVICA (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats
B García-Bueno et al.
BIOLOGICAL PSYCHIATRY (2005)
Neurochemical changes in LPA1 receptor deficient mice -: A putative model of schizophrenia
C Roberts et al.
NEUROCHEMICAL RESEARCH (2005)
New perspectives in the studies on endocannabinoid and cannabis: A role for the endocannabinoid-arachidonic acid pathway in drug reward and long-lasting relapse to drug taking
T Yamamoto et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Genetic and genomic approaches to reward and addiction
AR Mohn et al.
NEUROPHARMACOLOGY (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease
SM Harrison et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
The endophenotype concept in psychiatry: Etymology and strategic intentions
II Gottesman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration
JH Halpern et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity
A Avital et al.
HIPPOCAMPUS (2003)
The role of spinal neuropeptides and prostaglandins in opioid physical dependence
T Trang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Induction of nuclear factor-κB in nucleus accumbens by chronic cocaine administration
E Ang et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The Th2-hypothesis of schizophrenia:: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
MJ Schwarz et al.
MEDICAL HYPOTHESES (2001)
The prevention of schizophrenia: What interventions are safe and effective?
R Warner
SCHIZOPHRENIA BULLETIN (2001)
The cannabinoid system and cytokine network
TW Klein et al.
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
Toward reformulating the diagnosis of schizophrenia
MT Tsuang et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Nonaffective psychosis after prenatal exposure to rubella
AS Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
